This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Devin Wakefield: Innovator in Cell Culture Monitoring
Introduction
Devin Wakefield is an accomplished inventor based in Belmont, California. He has made significant contributions to the field of cell culture monitoring through his innovative patent. His work focuses on improving the quality of cells in culture, which is crucial for various applications in biotechnology and medicine.
Latest Patents
Devin Wakefield holds a patent for an imaging-based system designed for monitoring the quality of cells in culture. This patent, which is titled "Imaging-based system for monitoring quality of cells in culture," describes techniques to regulate the treatment of a culture of cells that correspond to different cell categories. The system includes an imaging sensor that captures images of the culture and an incubator that maintains optimal conditions for cell growth. The processing of these images allows for the segmentation of the culture into multiple image segments, enabling the determination of the amount of culture corresponding to specific cell categories. This information is vital for regulating the treatment of the culture effectively.
Career Highlights
Devin Wakefield's career is marked by his dedication to advancing cell culture technologies. His innovative approach has led to the development of techniques that enhance the monitoring and treatment of cell cultures. His patent reflects his commitment to improving the efficiency and effectiveness of cell culture practices.
Collaborations
Devin has collaborated with notable colleagues, including Stuart Chambers and Britney L Ragunton. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.
Conclusion
Devin Wakefield is a pioneering inventor whose work in cell culture monitoring has the potential to transform practices in biotechnology. His innovative patent showcases his expertise and commitment to improving cell treatment methodologies.
